Migraine and Patent Foramen Ovale: State of the Science

Critical Care Nursing Clinics of North America

Volumn 21, Issue 4, 2009, Pages 471-491

  Fuller, Cindy J ^a   Jesurum, Jill T ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

Aura; Headache; Migraine; Patent foramen ovale; Stroke

Indexed keywords

BRAIN ISCHEMIA; COMORBIDITY; COST OF ILLNESS; EPIDEMIOLOGY; EVIDENCE BASED PRACTICE; HEART CATHETERIZATION; HUMAN; MIGRAINE; PATENT FORAMEN OVALE; PHYSIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SPREADING CORTICAL DEPRESSION; STROKE; THROMBOCYTE ACTIVATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

BRAIN ISCHEMIA; CAUSALITY; COMORBIDITY; CORTICAL SPREADING DEPRESSION; COST OF ILLNESS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EVIDENCE-BASED PRACTICE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MIGRAINE DISORDERS; PLATELET ACTIVATION; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; STROKE;

EID: 70849120999     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2009.07.011     Document Type: Review

References (156)

1. Wilmshurst P., and Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 100 2 (2001) 215-220
2. Dalla Volta G., Guindani M., Zavarise P., et al. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 6 4 (2005) 328-330
3. Domitrz I., Mieszkowski J., and Kwiecinski H. [The prevalence of patent foramen ovale in patients with migraine]. Neurol Neurochir Pol 38 2 (2004) 89-92 [in Polish]
4. Schwerzmann M., Nedeltchev K., Lagger F., et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65 (2005) 1415-1418
5. Anzola G.P., Magoni M., Guindani M., et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52 8 (1999) 1622-1625
6. Reisman M., Christofferson R.D., Jesurum J., et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45 4 (2005) 493-495
7. Dowson A., Mullen M.J., Peatfield R., et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117 11 (2008) 1397-1404
8. National Library of Medicine. Available at: clinicaltrials.gov. Accessed October 22, 2008.
9. Kwong W.J., and Pathak D.S. Validation of the eleven-point pain scale in the measurement of migraine headache pain. Cephalalgia 27 4 (2007) 336-342
10. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 7 (2001) 646-657
11. Cook N.R., Bensenor I.M., Lotufo P.A., et al. Migraine and coronary heart disease in women and men. Headache 42 8 (2002) 715-727
12. Cutrer F.M., and Huerter K. Migraine aura. Neurologist 13 3 (2007) 118-125
13. Quintela E., Castillo J., Munoz P., et al. Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia 26 9 (2006) 1051-1060
14. Headache classification subcommittee, International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl 1 (2004) 9-160
15. Leonardi M., Steiner T.J., Scher A.T., et al. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain 6 6 (2005) 429-440
16. Bigal M.E., Liberman J.N., and Lipton R.B. Age-dependent prevalence and clinical features of migraine. Neurology 67 2 (2006) 246-251
17. Aukerman G., Knutson D., and Miser W.F. Management of the acute migraine headache. Am Fam Physician 66 11 (2002) 2123-2130
18. Hawkins K., Wang S., and Rupnow M.F. Indirect cost burden of migraine in the United States. J Occup Environ Med 49 4 (2007) 368-374
19. Hawkins K., Wang S., and Rupnow M. Direct cost burden among insured US employees with migraine. Headache 48 4 (2008) 553-563
20. Berry P.A. Migraine disorder: workplace implications and solutions. AAOHN J 55 2 (2007) 51-56
21. Moloney M.F., Strickland O.L., DeRossett S.E., et al. The experiences of midlife women with migraines. J Nurs Scholarsh 38 3 (2006) 278-285
22. Bigal M.E., Bigal J.M., Betti M., et al. Evaluation of the impact of migraine and episodic tension-type headache on the quality of life and performance of a university student population. Headache 41 7 (2001) 710-719
23. Stronks D.L., Tulen J.H., Bussmann J.B., et al. Interictal daily functioning in migraine. Cephalalgia 24 4 (2004) 271-279
24. Barbanti P., Fabbrini G., Aurilia C., et al. A case-control study on excessive daytime sleepiness in episodic migraine. Cephalalgia 27 10 (2007) 1115-1119
25. Breslau N., and Davis G.C. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res 27 2 (1993) 211-221
26. Jelinski S.E., Magnusson J.E., and Becker W.J. Factors associated with depression in patients referred to headache specialists. Neurology 68 7 (2007) 489-495
27. Tietjen G.E., Herial N.A., Hardgrove J., et al. Migraine comorbidity constellations. Headache 47 6 (2007) 857-865
28. Lipton R.B., Stewart W.F., Sawyer J., et al. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache 41 9 (2001) 854-861
29. Meletiche D.M., Lofland J.H., and Young W.B. Quality-of-life differences between patients with episodic and transformed migraine. Headache 41 6 (2001) 573-578
30. Lipton R.B., Liberman J.N., Kolodner K.B., et al. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23 6 (2003) 441-450
31. Patel N.V., Bigal M.E., Kolodner K.B., et al. Prevalence and impact of migraine and probable migraine in a health plan. Neurology 63 8 (2004) 1432-1438
32. Breslau N., Davis G.C., and Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37 1 (1991) 11-23
33. Bordini C.A., Mariano da Silva H., Garbelini R.P., et al. Effect of preventive treatment on health-related quality of life in episodic migraine. J Headache Pain 6 5 (2005) 387-391
34. D'Amico D., Solari A., Usai S., et al. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26 6 (2006) 691-696
35. Silberstein S.D., and Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology 54 8 (2000) 1553
36. Wenzel R., Dortch M., Cady R., et al. Migraine headache misconceptions: barriers to effective care. Pharmacotherapy 24 5 (2004) 638-648
37. Buring J.E., Hebert P., Romero J., et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 52 2 (1995) 129-134
38. Carolei A., Marini C., and De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347 9014 (1996) 1503-1506
39. Etminan M., Takkouche B., Isorna F.C., et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330 7482 (2005) 63-66
40. Stang P.E., Carson A.P., Rose K.M., et al. Headache, cerebrovascular symptoms, and stroke: the atherosclerosis risk in communities study. Neurology 64 9 (2005) 1573-1577
41. Kruit M.C., van Buchem M.A., Hofman P.A., et al. Migraine as a risk factor for subclinical brain lesions. JAMA 291 4 (2004) 427-434
42. Kruit M.C., Launer L.J., Ferrari M.D., et al. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128 Pt 9 (2005) 2068-2077
43. Milhaud D., Bogousslavsky J., van Melle G., et al. Ischemic stroke and active migraine. Neurology 57 10 (2001) 1805-1811
44. Robbins L., and Friedman H. MRI in migraineurs. Headache 32 10 (1992) 507-508
45. Gozke E., Ore O., Dortcan N., et al. Cranial magnetic resonance imaging findings in patients with migraine. Headache 44 2 (2004) 166-169
46. Swartz R.H., and Kern R.Z. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61 9 (2004) 1366-1368
47. Longstreth Jr. W.T., Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 27 8 (1996) 1274-1282
48. Riva D., Aggio F., Vago C., et al. Cognitive and behavioural effects of migraine in childhood and adolescence. Cephalalgia 26 5 (2006) 596-603
49. Calandre E.P., Bembibre J., Arnedo M.L., et al. Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. Cephalalgia 22 4 (2002) 291-302
50. Camarda C., Monastero R., Pipia C., et al. Interictal executive dysfunction in migraineurs without aura: relationship with duration and intensity of attacks. Cephalalgia 27 10 (2007) 1094-1100
51. Kurth T., Gaziano J.M., Cook N.R., et al. Migraine and risk of cardiovascular disease in women. JAMA 296 3 (2006) 283-291
52. Kurth T., Schurks M., Logroscino G., et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337 (2008) a636
53. Bigal M.E., and Lipton R.B. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67 2 (2006) 252-257
54. Bigal M.E., Tsang A., Loder E., et al. Body mass index and episodic headaches: a population-based study. Arch Intern Med 167 18 (2007) 1964-1970
55. MacClellan L.R., Giles W., Cole J., et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 38 9 (2007) 2438-2445
56. Wiehe M., Fuchs S.C., Moreira L.B., et al. Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20 7 (2002) 1303-1306
57. Gudmundsson L.S., Thorgeirsson G., Sigfusson N., et al. Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study. Cephalalgia 26 4 (2006) 436-444
58. Schurks M., Zee R.Y., Buring J.E., et al. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 71 7 (2008) 505-513
59. Sanchez-del-Rio M., and Reuter U. Migraine aura: new information on underlying mechanisms. Curr Opin Neurol 17 3 (2004) 289-293
60. Hadjikhani N., Sanchez Del Rio M., Wu O., et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98 8 (2001) 4687-4692
61. Choudhuri R., Cui L., Yong C., et al. Cortical spreading depression and gene regulation: relevance to migraine. Ann Neurol 51 4 (2002) 499-506
62. Urbach A., Bruehl C., and Witte O.W. Microarray-based long-term detection of genes differentially expressed after cortical spreading depression. Eur J Neurosci 24 3 (2006) 841-856
63. Gursoy-Ozdemir Y., Qiu J., Matsuoka N., et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113 10 (2004) 1447-1455
64. Bolay H., Reuter U., Dunn A.K., et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 2 (2002) 136-142
65. Battelli L., Black K.R., and Wray S.H. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology 58 7 (2002) 1066-1069
66. Khedr E.M., Ahmed M.A., and Mohamed K.A. Motor and visual cortical excitability in migraineurs patients with or without aura: transcranial magnetic stimulation. Neurophysiol Clin 36 1 (2006) 13-18
67. Hershey A.D., Tang Y., Powers S.W., et al. Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache 44 10 (2004) 994-1004
68. Zeller J.A., Frahm K., Baron R., et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?. J Neurol Neurosurg Psychiatry 75 7 (2004) 984-987
69. Fujita S. Effects of correcting platelet hyper-aggregability on prevention of migraine with aura manifested by scintillating scotoma and on migraine outcome using the MIDAS scale. Headache Care 3 2 (2006) 65-72
70. Sarchielli P., Alberti A., Coppola F., et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. Cephalalgia 24 8 (2004) 623-630
71. Zeller J.A., Lindner V., Frahm K., et al. Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia 25 7 (2005) 536-541
72. Aukrust P., Muller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100 6 (1999) 614-620
73. Chakrabarti S., Varghese S., Vitseva O., et al. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 25 11 (2005) 2428-2434
74. Mason P.J., Chakrabarti S., Albers A.A., et al. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Am J Cardiol 96 10 (2005) 1365-1369
75. Tietjen G.E., Al-Qasmi M.M., Athanas K., et al. Altered hemostasis in migraineurs studied with a dynamic flow system. Thromb Res 119 2 (2007) 217-222
76. Tietjen G.E., Al-Qasmi M.M., Athanas K., et al. Increased von Willebrand factor in migraine. Neurology 57 2 (2001) 334-336
77. Hering-Hanit R., Friedman Z., Schlesinger I., et al. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 21 2 (2001) 137-139
78. Corral J., Iniesta J.A., Gonzalez-Conejero R., et al. Migraine and prothrombotic genetic risk factors. Cephalalgia 18 5 (1998) 257-260
79. Schwaiger J., Kiechl S., Stockner H., et al. Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology 71 12 (2008) 937-943
80. Yetkin E., Ozisik H., Ozcan C., et al. Decreased endothelium-dependent vasodilatation in patients with migraine: a new aspect to vascular pathophysiology of migraine. Coron Artery Dis 17 1 (2006) 29-33
81. Lee S.T., Chu K., Jung K.H., et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 70 17 (2008) 1510-1517
82. Borroni B., Rao R., Liberini P., et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache 46 10 (2006) 1575-1579
83. Kerut E.K., Norfleet W.T., Plotnick G.D., et al. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 38 3 (2001) 613-623
84. Meissner I., Whisnant J.P., Khandheria B.K., et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 74 9 (1999) 862-869
85. Arquizan C., Coste J., Touboul P.J., et al. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 32 7 (2001) 1563-1566
86. Seib G. Incidence of the patent foramen ovale cordis in adult American whites and American negroes. Am J Anat 55 (1934) 511-525
87. Thompson T., and Evans V. Paradoxical embolism. Q J Med 23 (1930) 135-152
88. Hagen P.T., Scholz D.G., and Edwards W.D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59 1 (1984) 17-20
89. Di Tullio M.R., Sacco R.L., Sciacca R.R., et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49 7 (2007) 797-802
90. Pearson A.C., Labovitz A.J., Tatineni S., et al. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 17 1 (1991) 66-72
91. Di Tullio M., Sacco R.L., Venketasubramanian N., et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 24 7 (1993) 1020-1024
92. Sloan M.A., Alexandrov A.V., Tegeler C.H., et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62 9 (2004) 1468-1481
93. Spencer M.P., Moehring M.A., Jesurum J., et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 14 4 (2004) 342-349
94. Jesurum J.T., Fuller C.J., Kim C.J., et al. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Am J Cardiol 102 (2008) 916-920
95. Jesurum J.T., Fuller C.J., Moehring M.A., et al. Unilateral versus bilateral middle cerebral artery detection of right-to-left shunt by power m-mode transcranial Doppler. J Neuroimaging 19 3 (2009) 235-241
96. Del Sette M., Dinia L., Rizzi D., et al. Diagnosis of right-to-left shunt with transcranial Doppler and vertebrobasilar recording. Stroke 38 8 (2007) 2254-2256
97. Sacco R.L., Ellenberg J.H., Mohr J.P., et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 25 4 (1989) 382-390
98. Cramer S.C., Rordorf G., Maki J.H., et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) Study. Stroke 35 1 (2004) 46-50
99. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 18 (1988) 1148-1152
100. Webster M.W., Chancellor A.M., Smith H.J., et al. Patent foramen ovale in young stroke patients. Lancet 2 8601 (1988) 11-12
101. Cabanes L., Mas J.L., Cohen A., et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24 12 (1993) 1865-1873
102. de Belder M.A., Tourikis L., Leech G., et al. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 69 16 (1992) 1316-1320
103. Di Tullio M., Sacco R.L., Gopal A., et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 117 6 (1992) 461-465
104. Hausmann D., Mugge A., Becht I., et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 70 6 (1992) 668-672
105. Overell J.R., Bone I., and Lees K.R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55 8 (2000) 1172-1179
106. Handke M., Harloff A., Olschewski M., et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357 22 (2007) 2262-2268
107. De Castro S., Cartoni D., Fiorelli M., et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31 10 (2000) 2407-2413
108. Steiner M.M., Di Tullio M.R., Rundek T., et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29 5 (1998) 944-948
109. Homma S., Sacco R.L., Di Tullio M.R., et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105 22 (2002) 2625-2631
110. Stone D.A., Godard J., Corretti M.C., et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 131 1 (1996) 158-161
111. Anzola G.P., Zavarize P., Morandi E., et al. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol 10 2 (2003) 129-135
112. Hanley P.C., Tajik A.J., Hynes J.K., et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6 6 (1985) 1370-1382
113. Mas J.L., Arquizan C., Lamy C., et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345 24 (2001) 1740-1746
114. Karttunen V., Hiltunen L., Rasi V., et al. Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 14 3 (2003) 261-268
115. Lichy C., Reuner K.H., Buggle F., et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis 16 1 (2003) 83-87
116. Pezzini A., Del Zotto E., Magoni M., et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 34 1 (2003) 28-33
117. Belvis R., Santamaria A., Marti-Fabregas J., et al. Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 18 6 (2007) 537-542
118. Demirtas Tatlidede A., Oflazoglu B., Erten Celik S., et al. Prevalence of patent foramen ovale in patients with migraine. Agri 19 4 (2007) 39-42
119. Wilmshurst P.T., Pearson M.J., Nightingale S., et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 90 11 (2004) 1315-1320
120. Anzola G.P., Meneghetti G., Zanferrari C., et al. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM Study. Cephalalgia 28 4 (2008) 360-366
121. Tembl J., Lago A., Sevilla T., et al. Migraine, patent foramen ovale and migraine triggers. J Headache Pain 8 1 (2007) 7-12
122. Fukui P.T., Goncalves T.R., Strabelli C.G., et al. Trigger factors in migraine patients. Arq Neuropsiquiatr 66 3A (2008) 494-499
123. Gori S., Morelli N., Fanucchi S., et al. The extent of right-to-left shunt fails to correlate with severity of clinical picture in migraine with aura. Neurol Sci 27 1 (2006) 14-17
124. Rundek T., Elkind M.S., Di Tullio M.R., et al. Patent foramen ovale and migraine. A cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 118 14 (2008) 1419-1424
125. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113 10 (2006) e409-e449
126. Slottow T.L., Steinberg D.H., and Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation 116 6 (2007) 677-682
127. Wilmshurst P.T., Nightingale S., Walsh K.P., et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356 (2000) 1648-1651
128. Schwerzmann M., Wiher S., Nedeltchev K., et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62 8 (2004) 1399-1401
129. Slavin L., Tobis J.M., Rangarajan K., et al. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 99 9 (2007) 1316-1320
130. Anzola G.P., Frisoni G.B., Morandi E., et al. Shunt-associated migraine responds favorably to atrial septal repair. A case-control study. Stroke 37 2 (2006) 430-434
131. Wood S. NOMAS: just a 2% overlap for PFO and migraine; St. Jude shuts down ESCAPE trial. theheart.org. Accessed October 22, 2008.
132. Sarens T., Herroelen L., Van Deyk K., et al. Patent foramen ovale closure and migraine: are we following the wrong pathway?. J Neurol 256 1 (2009) 143-144
133. Rodes-Cabau J., Molina C., Serrano-Munuera C., et al. Migraine with aura related to the percutaneous closure of an atrial septal defect. Catheter Cardiovasc Interv 60 4 (2003) 540-542
134. Lai D.W., Saver J.L., Araujo J.A., et al. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter Cardiovasc Interv 66 3 (2005) 424-426
135. Wertman B., Azarbal B., Riedl M., et al. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol 47 6 (2006) 1226-1227
136. Ries M.W., Kampmann C., Rupprecht H.J., et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J 145 4 (2003) 737-741
137. Jesurum J.T., Fuller C.J., Velez C.A., et al. Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal features. J Headache Pain 8 4 (2007) 209-216
138. Renz J., Jesurum J.T., Fuller C.J., et al. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power m-mode transcranial Doppler. JACC Cardiovasc Interv 2 6 (2009) 561-567
139. Meissner I., Khandheria B.K., Heit J.A., et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47 2 (2006) 440-445
140. Silvestrini M., Baruffaldi R., Bartolini M., et al. Basilar and middle cerebral artery reactivity in patients with migraine. Headache 44 1 (2004) 29-34
141. Shanoudy H., Soliman A., Raggi P., et al. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 113 1 (1998) 91-96
142. van der Kuy P.-H.M., and Lohman J.J.H.M. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 22 (2002) 265-270
143. Macedo A., Farre M., and Banos J.E. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol 62 3 (2006) 161-172
144. Giardini A., Donti A., Formigari R., et al. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int J Cardiol 120 3 (2007) 357-362
145. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37 6 (2006) 1583-1633
146. Ridker P.M., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 13 (2005) 1293-1304
147. Lev E.I., Patel R.T., Maresh K.J., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47 1 (2006) 27-33
148. Qayyum R., Becker D.M., Yanek L.R., et al. Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease. Am J Cardiol 101 8 (2008) 1359-1363
149. Law M., Morris J.K., Jordan R., et al. Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants. Circulation 112 15 (2005) 2301-2306
150. Silberstein S.D., Neto W., Schmitt J., et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61 4 (2004) 490-495
151. Mathew N.T., and Loder E.W. Evaluating the triptans. Am J Med 118 Suppl 1 (2005) 28S-35S
152. Smith T., Blumenthal H., Diamond M., et al. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes. Headache 47 5 (2007) 683-692
153. Azarbal B., Tobis J., Suh W., et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45 4 (2005) 489-492
154. Dubiel M., Bruch L., Schmehl I., et al. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 21 1 (2008) 32-37
155. Shaygannejad V., Janghorbani M., Ghorbani A., et al. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Headache 46 4 (2006) 642-648
156. Brandes J.L., Kudrow D., Stark S.R., et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 297 13 (2007) 1443-1454